FCGBP and non-small cell lung carcinoma: In non-small cell lung cancer, FCGBP exhibits the highest mutation frequency among smoking-related genes, with its downregulation strongly correlating with enhanced tumor proliferation, migration, and immunosuppressive microenvironments in smokers [46].